These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23526884)

  • 21. Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules.
    Hagiwara S; Iki S; Urabe A; Saeki K; Miwa A; Togawa A; Ozawa K; Takaku F; Yuo A
    Int J Hematol; 1998 Dec; 68(4):387-401. PubMed ID: 9885438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes.
    Chandrasekar B; Mummidi S; Claycomb WC; Mestril R; Nemer M
    J Biol Chem; 2005 Feb; 280(6):4553-67. PubMed ID: 15574430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement for both JAK-mediated PI3K signaling and ACT1/TRAF6/TAK1-dependent NF-kappaB activation by IL-17A in enhancing cytokine expression in human airway epithelial cells.
    Huang F; Kao CY; Wachi S; Thai P; Ryu J; Wu R
    J Immunol; 2007 Nov; 179(10):6504-13. PubMed ID: 17982039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of human neutrophils by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha: role of phosphatidylinositol 3-kinase.
    Kamata N; Kutsuna H; Hato F; Kato T; Oshitani N; Arakawa T; Kitagawa S
    Int J Hematol; 2004 Dec; 80(5):421-7. PubMed ID: 15646653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha.
    Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S
    Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase.
    Colamonici M; Blyth G; Saleiro D; Szilard A; Bliss-Moreau M; Giles FJ; Altman JK; Beauchamp EM; Platanias LC
    Oncotarget; 2015 Apr; 6(10):8062-70. PubMed ID: 25823922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.
    Juss JK; Hayhoe RP; Owen CE; Bruce I; Walmsley SR; Cowburn AS; Kulkarni S; Boyle KB; Stephens L; Hawkins PT; Chilvers ER; Condliffe AM
    PLoS One; 2012; 7(9):e45933. PubMed ID: 23029326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
    Dovat E; Song C; Hu T; Rahman MA; Dhanyamraju PK; Klink M; Bogush D; Soliman M; Kane S; McGrath M; Ding Y; Desai D; Sharma A; Gowda C
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Shc-binding site of the betac subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis.
    Ramshaw HS; Guthridge MA; Stomski FC; Barry EF; Ooms L; Mitchell CA; Begley CG; Lopez AF
    Blood; 2007 Nov; 110(10):3582-90. PubMed ID: 17638849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of chemotactic peptide-induced activation of phosphoinositide 3-kinase by granulocyte-macrophage colony-stimulating factor and its relation to the cytokine-mediated priming of neutrophil superoxide-anion production.
    Kodama T; Hazeki K; Hazeki O; Okada T; Ui M
    Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):201-9. PubMed ID: 9882616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical role for PI 3-kinase in cytokine-induced Fcalpha-receptor activation.
    Bracke M; Nijhuis E; Lammers JW; Coffer PJ; Koenderman L
    Blood; 2000 Mar; 95(6):2037-43. PubMed ID: 10706872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of phosphoinositide 3-kinase and extracellular signal-regulated kinase pathways in granulocyte macrophage-colony-stimulating factor failure to delay fas-induced neutrophil apoptosis in elderly humans.
    Tortorella C; Simone O; Piazzolla G; Stella I; Cappiello V; Antonaci S
    J Gerontol A Biol Sci Med Sci; 2006 Nov; 61(11):1111-8. PubMed ID: 17167151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5.
    Coffer PJ; Schweizer RC; Dubois GR; Maikoe T; Lammers JW; Koenderman L
    Blood; 1998 Apr; 91(7):2547-57. PubMed ID: 9516156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL- and mutant FLT3-expressing cells.
    Weisberg E; Banerji L; Wright RD; Barrett R; Ray A; Moreno D; Catley L; Jiang J; Hall-Meyers E; Sauveur-Michel M; Stone R; Galinsky I; Fox E; Kung AL; Griffin JD
    Blood; 2008 Apr; 111(7):3723-34. PubMed ID: 18184863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.
    Chapuis N; Tamburini J; Green AS; Vignon C; Bardet V; Neyret A; Pannetier M; Willems L; Park S; Macone A; Maira SM; Ifrah N; Dreyfus F; Herault O; Lacombe C; Mayeux P; Bouscary D
    Clin Cancer Res; 2010 Nov; 16(22):5424-35. PubMed ID: 20884625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit.
    Sun J; Pedersen M; Rönnstrand L
    J Biol Chem; 2008 Oct; 283(41):27444-27451. PubMed ID: 18697750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological targeting of the PI3K/mTOR pathway alters the release of angioregulatory mediators both from primary human acute myeloid leukemia cells and their neighboring stromal cells.
    Reikvam H; Nepstad I; Bruserud Ø; Hatfield KJ
    Oncotarget; 2013 Jun; 4(6):830-43. PubMed ID: 23919981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) receptors in a GM-CSF-dependent human myeloid leukemia cell line (AML-193) by interleukin-6.
    Li Y; Valeriote F; Chen B
    Exp Hematol; 1996 Feb; 24(2):94-100. PubMed ID: 8641372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic evaluation of anti-apoptotic growth factor signaling in vascular smooth muscle cells. Only phosphatidylinositol 3'-kinase is important.
    Vantler M; Caglayan E; Zimmermann WH; Bäumer AT; Rosenkranz S
    J Biol Chem; 2005 Apr; 280(14):14168-76. PubMed ID: 15640155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.